Jan Gettemans is full professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is research on nanobodies (single domain antibodies) and their implementation in a diverse array of (bio)medical settings.

Our lab leverages the power of chemistry, biotechnology and nanotechnology to engineer the immune system at better responding to internal threats such as cancer and external threats such as viral pathogens and lethal drug substances. In this context we aim to intervene at different levels in the process of innate immune activation, antigen presentation and the generation of adaptive immunity to clear or protect the host from a specific threat. 

Hendrik Feys is a Principal Investigator at the Belgian Red Cross Flanders Transfusion Research Center. The center has a research focus on blood derived products and their applicability in regenerative medicine. Hendrik  is a visiting professor at the Department of Diagnostics Sciences at Ghent University.

Director of the Lab of General Biochemistry & Physical Pharmacy at UGent. Served as dean of his Faculty and member of Board of Directors of UGent. Has been a Guest Professor at various universities in Belgium and China and is Deputy Editor-in-Chief of the Journal of Controlled Release. His research is at the interface between drug delivery, biophysics and material sciences.

Frank Speleman is professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is the study of perturbed gene regulatory processes in paediatric cancer, more specifically neuroblastoma and T-ALL.

Nico Callewaert is group leader and director of the VIB-UGent Center for Medical Biotechnology and full professor in biochemistry and biotechnology at Ghent University. His research interests focus on the invention of technologies for medicine, proteins and sugars.  

Kevin Braeckmans is Full Professor at Ghent University, faculty of Pharmaceutical Sciences. He is co-director of the Lab. Of General Biochemistry and Physical Pharmacy and group leader of the Biophotonics Research Group. His focus is on light-based technologies for investigating and facilitating drug delivery to cells and tissues, including for cell therapy applications.

Former Chairman of the Department of Plastic Surgery and Burn Center at the Ghent University Hospital.

Prof. Jolanda van Hengel is heading the medical cell biology group. Her group focuses on the in vitro engineering of functional myocardium that mimics human heart tissue for analysis of myocardial function. Also her group tries to obtain a suitable stem cell type for in vitro meat production.

Page 1 of 2

BROCHURES

Contact us

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

© Gate Health. All rights reserved. Powered by GESELLE.be.